Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Fruchart

Showing results (61-70 of 538) with videos related to

Pageof 54
Sort By:
Pharmacological Research|November 20, 2001
PPARS, metabolic disease and atherosclerosisJ C Fruchart, B Staels, P Duriez
Journal De La Societe De Biologie|June 14, 2000
[Molecular mechanism of action of the fibrates]J C Fruchart, P Duriez, B Staels
Arzneimittel-Forschung|January 1, 1977
[Inhibition by "essential" phospholipids of the bactericidal effect of cetylpyridinium chloride on common bacteria. Short communication]A Fruchart, B Carbonelle, J C Fruchart
Current Opinion in Lipidology|October 1, 1995
Apolipoprotein A-I-containing lipoproteins and atherosclerosisA Leroy, J Dallongeville, J C Fruchart
Israel Journal of Medical Sciences|June 1, 1996
Apolipoprotein-AI-containing particles and atherosclerosisJ C Fruchart, G Castro, P Duriez
Cellular and Molecular Life Sciences : CMLS|July 21, 1999
An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancerL Gelman, J C Fruchart, J Auwerx
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|February 1, 1974
[New method of determination of the lipase activity of the serum. Clinical applications]J C Fruchart, G Sezille, J Jaillard
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 31, 2004
PPAR alpha, fibrates, lipid metabolism and inflammationC Duval, J C Fruchart, B Staels
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1991
[Conformational changes in lipoproteins containing apo B: significance of monoclonal antibodies]P Harduin, C Fiévet, J C Fruchart
Journees Annuelles De Diabetologie De L'Hotel-Dieu|July 10, 2008
[PPAR receptors at the crossroads of obesity, diabetes and cardiovascular diseases]A Gilde, J-C Fruchart, B Staels
Pageof 54

Showing results (61-70 of 538) with videos related to

Sort By:
Pageof 54
Pharmacological Research|November 20, 2001
PPARS, metabolic disease and atherosclerosisJ C Fruchart, B Staels, P Duriez
Journal De La Societe De Biologie|June 14, 2000
[Molecular mechanism of action of the fibrates]J C Fruchart, P Duriez, B Staels
Arzneimittel-Forschung|January 1, 1977
[Inhibition by "essential" phospholipids of the bactericidal effect of cetylpyridinium chloride on common bacteria. Short communication]A Fruchart, B Carbonelle, J C Fruchart
Current Opinion in Lipidology|October 1, 1995
Apolipoprotein A-I-containing lipoproteins and atherosclerosisA Leroy, J Dallongeville, J C Fruchart
Israel Journal of Medical Sciences|June 1, 1996
Apolipoprotein-AI-containing particles and atherosclerosisJ C Fruchart, G Castro, P Duriez
Cellular and Molecular Life Sciences : CMLS|July 21, 1999
An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancerL Gelman, J C Fruchart, J Auwerx
Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille|February 1, 1974
[New method of determination of the lipase activity of the serum. Clinical applications]J C Fruchart, G Sezille, J Jaillard
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 31, 2004
PPAR alpha, fibrates, lipid metabolism and inflammationC Duval, J C Fruchart, B Staels
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1991
[Conformational changes in lipoproteins containing apo B: significance of monoclonal antibodies]P Harduin, C Fiévet, J C Fruchart
Journees Annuelles De Diabetologie De L'Hotel-Dieu|July 10, 2008
[PPAR receptors at the crossroads of obesity, diabetes and cardiovascular diseases]A Gilde, J-C Fruchart, B Staels
Pageof 54